Literature DB >> 28349273

Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer.

Yaeji Lim1, Eun Sook Ko2, Boo-Kyung Han3, Eun Young Ko3, Ji Soo Choi3, Jeong Eon Lee4, Se Kyung Lee4.   

Abstract

PURPOSE: To determine whether BPE in preoperative breast MRI influences patients' recurrence-free survival (RFS).
METHODS: Between February 2010 and December 2011, 804 consecutive women with invasive breast cancer who had undergone preoperative breast MRI and curative cancer surgery were identified. BPE was visually graded by two reviewers. We determined the correlation between BPE grade and other clinicopathological variables, including age, adjuvant therapy, menopausal status, histologic grade, T stage, N stage, lymphovascular invasion, molecular subtype, surgical margin status, and mammographic density. A Cox proportional hazards model was used to analyze the effects of clinicopathological variables and radiological findings (BPE grade, mammographic density) on RFS.
RESULTS: High BPE was associated with premenopausal status (Ps < 0.0001), higher mammographic density (Ps < 0.0001), progesterone receptor positivity (Ps = 0.039, 0.007, respectively), presence of lymphovascular invasion (Ps = 0.008, 0.001, respectively), and close surgical margin (Ps < 0.0001). Recurrences were observed in 75 patients after a mean follow-up period of 61.8 months (range 4-81 months). Non-minimal BPE grade (RFS hazard ratio = 3.086, P = 0.003 for reader 1; RFS hazard ratio = 2.221, P = 0.075 for reader 2) and T3 stage were associated with worse outcomes in postmenopausal women. In premenopausal women, non-minimal BPE grade by readers 1 and 2 did not affect the patients' outcomes.
CONCLUSIONS: Increased BPE on preoperative breast MRI in postmenopausal women has potential as a predictor of poor RFS.

Entities:  

Keywords:  Background parenchymal enhancement; Breast cancer; Magnetic resonance imaging; Menopausal status; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 28349273     DOI: 10.1007/s10549-017-4217-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

Review 1.  Background parenchymal enhancement on breast MRI: A comprehensive review.

Authors:  Geraldine J Liao; Leah C Henze Bancroft; Roberta M Strigel; Rhea D Chitalia; Despina Kontos; Linda Moy; Savannah C Partridge; Habib Rahbar
Journal:  J Magn Reson Imaging       Date:  2019-04-19       Impact factor: 4.813

2.  High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.

Authors:  Chuanhui Xu; Jinhui Yu; Feifei Wu; Xuemei Li; Dongmin Hu; Guiming Chen; Gang Wu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker.

Authors:  Rossella Rella; Andrea Contegiacomo; Enida Bufi; Sara Mercogliano; Paolo Belli; Riccardo Manfredi
Journal:  Br J Radiol       Date:  2020-10-15       Impact factor: 3.039

4.  Invited Discussion on: Clinical and MRI Evaluation of Silicone Gel Implants with RFID-M Traceability System: A Prospective Controlled Cohort Study Related to Safety and Image Quality in MRI Follow-Up.

Authors:  Fereydoun D Parsa; Dylan Singh
Journal:  Aesthetic Plast Surg       Date:  2021-06-28       Impact factor: 2.326

5.  Metabolic Activity of Normal Glandular Tissue on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Correlation with Menstrual Cycles and Parenchymal Enhancements.

Authors:  Young-Sil An; Yongsik Jung; Ji Young Kim; Sehwan Han; Doo Kyoung Kang; Seon Young Park; Tae Hee Kim
Journal:  J Breast Cancer       Date:  2017-12-19       Impact factor: 3.588

6.  Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer.

Authors:  Jun Li; Yin Mo; Bo He; Qian Gao; Chunyan Luo; Chao Peng; Wei Zhao; Yun Ma; Ying Yang
Journal:  Br J Radiol       Date:  2019-08-09       Impact factor: 3.039

7.  MRI-Based Radiomics for Preoperative Prediction of Lymphovascular Invasion in Patients With Invasive Breast Cancer.

Authors:  Mayidili Nijiati; Diliaremu Aihaiti; Aisikaerjiang Huojia; Abudukeyoumujiang Abulizi; Sailidan Mutailifu; Nueramina Rouzi; Guozhao Dai; Patiman Maimaiti
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

8.  Prognostic Factors of Disease Recurrence in Breast Cancer Using Quantitative and Qualitative Magnetic Resonance Imaging (MRI) Parameters.

Authors:  Jeongmin Lee; Sung Hun Kim; Bong Joo Kang
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

9.  MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.

Authors:  Roberto Lo Gullo; Isaac Daimiel; Carolina Rossi Saccarelli; Almir Bitencourt; Varadan Sevilimedu; Danny F Martinez; Maxine S Jochelson; Elizabeth A Morris; Jeffrey S Reiner; Katja Pinker
Journal:  Breast Cancer Res       Date:  2020-08-20       Impact factor: 6.466

10.  Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score.

Authors:  Michelle Zhang; Meredith Sadinski; Dana Haddad; Min Sun Bae; Danny Martinez; Elizabeth A Morris; Peter Gibbs; Elizabeth J Sutton
Journal:  Front Oncol       Date:  2021-02-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.